That's great news because we do know the success that is evident by the number of samplings you're diagnosing on an annual basis and how they are exponentially growing. I suspect that's going to continue as people become more aware of the world-leading study you're doing and the diagnosing you're doing in such a quick way.
We thank you for that. We'll continue to monitor the developments of those applications and of your plans to continue.
Thanks so much for all you do. I'll leave it there and end by simply thanking all of you for joining us today.